For the quarter ended June 2026, Procter & Gamble (PG Quick QuotePG - Free Report) reported revenue of $21.2 billion, up 1.5% over the same period last year. EPS came in at $1.43, compared to $1.48 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $21.36 billion, representing a surprise of -0.73%. The company delivered an EPS surprise of +1.42%, with the consensus EPS estimate being $1.41.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic Sales Growth (YoY change) - Beauty: 4% versus the five-analyst average estimate of 3.2%.
• Organic Sales Growth (YoY change) - Baby, Feminine & Family Care: -2% compared to the 0.3% average estimate based on five analysts.
• Organic Sales Growth (YoY change) - Health Care: -1% versus the five-analyst average estimate of 1.3%.
• Net Sales- Beauty: $3.98 billion versus $3.88 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change.
• Net Sales- Grooming: $1.7 billion versus $1.71 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1% change.
• Net Sales- Corporate: $292 million versus the six-analyst average estimate of $250.59 million. The reported number represents a year-over-year change of +6.6%.
• Net Sales- Fabric & Home Care: $7.43 billion versus the six-analyst average estimate of $7.51 billion. The reported number represents a year-over-year change of +0.6%.
• Net Sales- Baby, Feminine & Family Care: $5.05 billion versus the six-analyst average estimate of $5.12 billion. The reported number represents a year-over-year change of -0.9%.
• Net Sales- Health Care: $2.76 billion compared to the $2.79 billion average estimate based on six analysts. The reported number represents a change of +1.3% year over year.
• Earnings before income taxes- Beauty: $588 million versus the three-analyst average estimate of $714.12 million.
• Earnings before income taxes- Grooming: $414 million versus $446.33 million estimated by three analysts on average.
• Earnings before income taxes- Health Care: $449 million compared to the $477.62 million average estimate based on three analysts.

View all Key Company Metrics for P&G here>>>

Shares of P&G have returned +1.5% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.